Research Article

Evaluation of the neuropathic component of pain in patients with fibromyalgia with painDETECT and DN4

Volume: 41 Number: 2 May 19, 2024
EN

Evaluation of the neuropathic component of pain in patients with fibromyalgia with painDETECT and DN4

Abstract

Fibromyalgia (FMS) is generally associated with neuropathic pain (NP) because of the neuropathic symptoms frequently observed in patients with FMS. The aim of the study is to evaluate the neuropathic component of FMS with the painDETECT (PD-Q) and Douler Neuropathic 4 (DN4) scales. Female patients diagnosed as FMS according to the American College of Rheumatology’s 2010 FMS criteria and female healthy volunteers are included in the study. After demographic evaluation, the patients and volunteers were asked to fill out Visual Analog Score (VAS), PD-Q, and DN4 scale forms. The Fibromyalgia Impairment Questionnaire (FIQ) evaluated life quality and function. There were 66 patients in the FMS group with a mean age of 46.16± 10.66 and 61 patients in the control group with a mean age of 44.93± 12.72. It was determined that there was a significant difference between the VAS, PD-Q, and DN4 values of FMS and control groups (tVAS = 5,025 p < 0.05, t PD-Q = 5,025 p < 0.05, tDN4 = 7,885 p < 0.05). The mean pain score (VAS) and NP level (DN4 and PD-Q) of FMS patients were significantly higher than healthy individuals. In addition, it was determined that VAS (p = 0.001) and PD-Q (p = 0.046) values were found to be significant predictors of the FIQ values. FMS patients may have pain with a neuropathic component, and it seems useful to evaluate neuropathic characteristics with PD-Q and DN4. If the components of pain are researched carefully, more improvement may be achieved in pain and functional capacity.

Keywords

Supporting Institution

We did not have any support or funding during the study.

Project Number

0626

Ethical Statement

We declare that we have no ethical problem, conflict of interest or financial interest in the current study. We declare that the article has not been previously published, all authors contribute the data in article and the data is totally original.

Thanks

Thank you for your time for evaluating this study. Acknowledgement: None

References

  1. Borchers AT, Gershwin ME. Fibromyalgia: A Critical and Comprehensive Review. Clin Rev Allergy Immunol 2015; 49(2):100-51.
  2. Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 2013; 17(8):356.
  3. Cheng CW, Wong CS, Hui GK, Chung EK, Wong SH. Fibromyalgia: is it a neuropathic pain? Pain Manag 2018; 8(5):377-388.
  4. Albrecht PJ, Rice FL. Fibromyalgia syndrome pathology and environmental influences on afflictions with medically unexplained symptoms. Rev Environ Health 2016; 31(2):281-94.
  5. Fleming KC, Volcheck MM. Central sensitization syndrome and the initial evaluation of a patient with fibromyalgia: a review. Rambam Maimonides Med J. 2015; 6(2):e0020.
  6. Attal N, Bouhassira D, Baron R. Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol. 2018 May;17(5):456-466.
  7. Kösehasanoğullari M, Erdinç Gündüz N, Akalin E. Is Fibromyalgia Syndrome a Neuropathic Pain Syndrome? Arch Rheumatol 2018; 34(2):196-203.
  8. Martínez-Lavin M, López S, Medina M, Nava A. Use of the leeds assessment of neuropathic symptoms and signs question-naire in patients with fibromyalgia. Semin. Arthritis Rheum. 2003;32:407–411.

Details

Primary Language

English

Subjects

Rheumatology and Arthritis

Journal Section

Research Article

Publication Date

May 19, 2024

Submission Date

December 19, 2023

Acceptance Date

April 17, 2024

Published in Issue

Year 2024 Volume: 41 Number: 2

APA
Demirdal, Ü. S., Küçülmez, Ö., Aşkın, A., Tosun, A., & Koçak, D. (2024). Evaluation of the neuropathic component of pain in patients with fibromyalgia with painDETECT and DN4. Deneysel Ve Klinik Tıp Dergisi, 41(2), 246-252. https://izlik.org/JA48AW63ST
AMA
1.Demirdal ÜS, Küçülmez Ö, Aşkın A, Tosun A, Koçak D. Evaluation of the neuropathic component of pain in patients with fibromyalgia with painDETECT and DN4. J. Exp. Clin. Med. 2024;41(2):246-252. https://izlik.org/JA48AW63ST
Chicago
Demirdal, Ümit Seçil, Özlem Küçülmez, Ayhan Aşkın, Aliye Tosun, and Duygu Koçak. 2024. “Evaluation of the Neuropathic Component of Pain in Patients With Fibromyalgia With PainDETECT and DN4”. Deneysel Ve Klinik Tıp Dergisi 41 (2): 246-52. https://izlik.org/JA48AW63ST.
EndNote
Demirdal ÜS, Küçülmez Ö, Aşkın A, Tosun A, Koçak D (May 1, 2024) Evaluation of the neuropathic component of pain in patients with fibromyalgia with painDETECT and DN4. Deneysel ve Klinik Tıp Dergisi 41 2 246–252.
IEEE
[1]Ü. S. Demirdal, Ö. Küçülmez, A. Aşkın, A. Tosun, and D. Koçak, “Evaluation of the neuropathic component of pain in patients with fibromyalgia with painDETECT and DN4”, J. Exp. Clin. Med., vol. 41, no. 2, pp. 246–252, May 2024, [Online]. Available: https://izlik.org/JA48AW63ST
ISNAD
Demirdal, Ümit Seçil - Küçülmez, Özlem - Aşkın, Ayhan - Tosun, Aliye - Koçak, Duygu. “Evaluation of the Neuropathic Component of Pain in Patients With Fibromyalgia With PainDETECT and DN4”. Deneysel ve Klinik Tıp Dergisi 41/2 (May 1, 2024): 246-252. https://izlik.org/JA48AW63ST.
JAMA
1.Demirdal ÜS, Küçülmez Ö, Aşkın A, Tosun A, Koçak D. Evaluation of the neuropathic component of pain in patients with fibromyalgia with painDETECT and DN4. J. Exp. Clin. Med. 2024;41:246–252.
MLA
Demirdal, Ümit Seçil, et al. “Evaluation of the Neuropathic Component of Pain in Patients With Fibromyalgia With PainDETECT and DN4”. Deneysel Ve Klinik Tıp Dergisi, vol. 41, no. 2, May 2024, pp. 246-52, https://izlik.org/JA48AW63ST.
Vancouver
1.Ümit Seçil Demirdal, Özlem Küçülmez, Ayhan Aşkın, Aliye Tosun, Duygu Koçak. Evaluation of the neuropathic component of pain in patients with fibromyalgia with painDETECT and DN4. J. Exp. Clin. Med. [Internet]. 2024 May 1;41(2):246-52. Available from: https://izlik.org/JA48AW63ST